Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result

Giant cell tumor of bone (GCTB) has a high local recurrence rate of approximately 20%. Systemic inflammatory markers, such as neutrophil-lymphocyte ratio (NLR), modified Glasgow prognostic score (mGPS), prognostic nutritional index (PNI), lymphocyte-monocyte ratio (LMR), platelet-lymphocyte ratio (P...

Full description

Bibliographic Details
Main Authors: Shinji Tsukamoto, Andreas F. Mavrogenis, Rebeca Angulo Alvarado, Matteo Traversari, Manabu Akahane, Kanya Honoki, Yasuhito Tanaka, Davide Maria Donati, Costantino Errani
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/30/1/85
_version_ 1797443965954293760
author Shinji Tsukamoto
Andreas F. Mavrogenis
Rebeca Angulo Alvarado
Matteo Traversari
Manabu Akahane
Kanya Honoki
Yasuhito Tanaka
Davide Maria Donati
Costantino Errani
author_facet Shinji Tsukamoto
Andreas F. Mavrogenis
Rebeca Angulo Alvarado
Matteo Traversari
Manabu Akahane
Kanya Honoki
Yasuhito Tanaka
Davide Maria Donati
Costantino Errani
author_sort Shinji Tsukamoto
collection DOAJ
description Giant cell tumor of bone (GCTB) has a high local recurrence rate of approximately 20%. Systemic inflammatory markers, such as neutrophil-lymphocyte ratio (NLR), modified Glasgow prognostic score (mGPS), prognostic nutritional index (PNI), lymphocyte-monocyte ratio (LMR), platelet-lymphocyte ratio (PLR), hemoglobin (Hb), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH), have been reported as prognostic markers in patients with malignant tumors. This study aimed to investigate the correlation between these markers and the local recurrence rate of GCTB. In total, 103 patients with GCTB who underwent surgery at the authors’ institutions between 1993 and 2021 were included. Thirty patients experienced local recurrence. Univariate and multivariate analysis showed that tumor site, preoperative and postoperative denosumab treatment, and surgery were significantly associated with local recurrence-free survival. LDH was associated with local recurrence-free survival on univariate analysis only. NLR, mGPS, PNI, LMR, and PLR score did not correlate with the local recurrence rate. In conclusion, NLR, mGPS, PNI, LMR, PLR score, Hb, ALP, and LDH levels are not correlated with the local recurrence rate of GCTB. However, due to the small number of patients included in this study, this result should be re-evaluated in a multicenter study with a larger sample size.
first_indexed 2024-03-09T13:04:46Z
format Article
id doaj.art-6f6abd0ba91f4651a8d8aee1048f9720
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T13:04:46Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-6f6abd0ba91f4651a8d8aee1048f97202023-11-30T21:50:03ZengMDPI AGCurrent Oncology1198-00521718-77292023-01-013011116113110.3390/curroncol30010085Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary ResultShinji Tsukamoto0Andreas F. Mavrogenis1Rebeca Angulo Alvarado2Matteo Traversari3Manabu Akahane4Kanya Honoki5Yasuhito Tanaka6Davide Maria Donati7Costantino Errani8Department of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Nara, JapanFirst Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine,41 Ventouri Street, 15562 Athens, GreeceDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, ItalyDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, ItalyDepartment of Health and Welfare Services, National Institute of Public Health, 2-3-6 Minami, Wako-shi 351-0197, Saitama, JapanDepartment of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, ItalyDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, ItalyGiant cell tumor of bone (GCTB) has a high local recurrence rate of approximately 20%. Systemic inflammatory markers, such as neutrophil-lymphocyte ratio (NLR), modified Glasgow prognostic score (mGPS), prognostic nutritional index (PNI), lymphocyte-monocyte ratio (LMR), platelet-lymphocyte ratio (PLR), hemoglobin (Hb), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH), have been reported as prognostic markers in patients with malignant tumors. This study aimed to investigate the correlation between these markers and the local recurrence rate of GCTB. In total, 103 patients with GCTB who underwent surgery at the authors’ institutions between 1993 and 2021 were included. Thirty patients experienced local recurrence. Univariate and multivariate analysis showed that tumor site, preoperative and postoperative denosumab treatment, and surgery were significantly associated with local recurrence-free survival. LDH was associated with local recurrence-free survival on univariate analysis only. NLR, mGPS, PNI, LMR, and PLR score did not correlate with the local recurrence rate. In conclusion, NLR, mGPS, PNI, LMR, PLR score, Hb, ALP, and LDH levels are not correlated with the local recurrence rate of GCTB. However, due to the small number of patients included in this study, this result should be re-evaluated in a multicenter study with a larger sample size.https://www.mdpi.com/1718-7729/30/1/85giant cell tumor of boneneutrophil-lymphocyte ratiomodified Glasgow prognostic scoreprognostic nutrient indexlymphocyte-monocyte ratioplatelet-lymphocyte ratio
spellingShingle Shinji Tsukamoto
Andreas F. Mavrogenis
Rebeca Angulo Alvarado
Matteo Traversari
Manabu Akahane
Kanya Honoki
Yasuhito Tanaka
Davide Maria Donati
Costantino Errani
Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
Current Oncology
giant cell tumor of bone
neutrophil-lymphocyte ratio
modified Glasgow prognostic score
prognostic nutrient index
lymphocyte-monocyte ratio
platelet-lymphocyte ratio
title Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
title_full Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
title_fullStr Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
title_full_unstemmed Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
title_short Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
title_sort association between inflammatory markers and local recurrence in patients with giant cell tumor of bone a preliminary result
topic giant cell tumor of bone
neutrophil-lymphocyte ratio
modified Glasgow prognostic score
prognostic nutrient index
lymphocyte-monocyte ratio
platelet-lymphocyte ratio
url https://www.mdpi.com/1718-7729/30/1/85
work_keys_str_mv AT shinjitsukamoto associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT andreasfmavrogenis associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT rebecaanguloalvarado associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT matteotraversari associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT manabuakahane associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT kanyahonoki associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT yasuhitotanaka associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT davidemariadonati associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult
AT costantinoerrani associationbetweeninflammatorymarkersandlocalrecurrenceinpatientswithgiantcelltumorofboneapreliminaryresult